|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
A.I. Dyadyk, Т.Е. Kugler, E.V. Schukina, I.V. Rakitskaya, S.R. Zborovsky, Yu.V. Suliman
DIURETHIC RESISTANCE: MECHANISMS, MEDICAL TACTICS AND PREVENTION
|
№18 / 2017
|
|
I.T. Murkamilov (1, 2), K.A. Aitbayev (3), V.V. Fomin (4), Z.R. Rayimzhanov (5), N.A. Redzhapova (6), F.A. Yusupov (6), Z.A. Aydarov (1)
SUPPRESSION OF PROGRESSION OF RENAL DYSFUNCTION AND CEREBROVASCULAR EVENTS: POTENTIALS OF ATORVASTATIN
|
№15 / 2017
|
|
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
|
№9 / 2017
|
|
I.T. Murkamilov (1), K.A. Aytbaev (2), F.A. Yusupov (3)
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
|
№5 / 2017
|
|
N.P. Lyamina, A.V. Nalivaeva
CARDIORENAL CONCEPT AND CURRENT POSITION OF NEPHROPROTECTION OF LERCANIDIPINE
|
№9 / 2016
|
|
M.S. Barylko, P.V. Seliverstov, V.G. Radchenko
THE USE OF ENTEROSORBENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT PREDIALYSIS STAGE
|
№6 / 2016
|
|
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
|
№3 / 2012
|
|
A.A. Pulin, T.V. Kustov, V.V. Fomin
Loop Diuretics: Whether The Well-established Standard Of Care Needs Reform?
|
№14 / 2011
|
|
E. Gornostayeva, E. Shilov, E. Akarachkova, S. Shvarkov С. 4448
Autonomic Dysfunction And Chronic Kidney Disease In Metabolic Syndrome: Principles Of Therapy
|
№20 / 2009
|
Русский
